International Stem Cell Corporation

International Stem Cell Corporation (ISCO) is a biotechnology company focused on the research, development, and commercialization of novel stem cell-based therapies and regenerative medicine products. The company leverages its proprietary parthenogenetic stem cell technology to generate human pluripotent stem cells (hPSCs) and their differentiated progeny. These cells hold significant potential for treating a wide range of degenerative diseases and conditions. ISCO's research efforts are directed towards developing cell-based therapies for indications with unmet medical needs. The company aims to improve patient outcomes through innovative regenerative medicine solutions. ISCO operates within the biotechnology sector, contributing to advancements in stem cell research and the development of novel therapeutic strategies.